How much funding has Curve Therapeutics raised?

Curve Therapeutics has raised $51.4M in total funding, most recently a Series A round.

Who are Curve Therapeutics's investors?

Curve Therapeutics's investors include Pfizer Ventures, Columbus Venture Partners, Advent Life Sciences, Epidarex Capital, British Patient Capital.

When was Curve Therapeutics founded?

Curve Therapeutics was founded in 2019.

Where is Curve Therapeutics headquartered?

Curve Therapeutics is headquartered in Southampton, United Kingdom.

What industry is Curve Therapeutics in?

Curve Therapeutics operates in Biotech.

How many employees does Curve Therapeutics have?

Curve Therapeutics has 11-50 employees.

Curve Therapeutics

Drug Discovery, Differently.

Southampton, United Kingdom · Founded 2019 · $51.4M raised

Biotech

Headquarters: Southampton
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: curvetx.com
Total Funding: $51.4M
Last Round: $51.4M Series AFeb 2024
Rounds: 1

About

Curve Therapeutics is a private UK biotechnology company using its proprietary mammalian cell-based Microcycle® discovery platform to discover novel cyclic peptide and small molecule drugs targeting intracellular disease targets. Founded as a University of Southampton spinout, the company focuses on cancer, immunology, and inflammation, with a pipeline of macrocycle-derived drugs that address targets conventional methods cannot reach. Its Microcycles are compact, rigid macrocycles that behave like small molecules, enabling functional screening inside living mammalian cells. The company raised a £40.5 million ($51M) Series A led by Pfizer Ventures in 2024.

Summary

Curve Therapeutics is a Biotech company based in Southampton, United Kingdom, founded in 2019. It has raised $51.4M in total across 1 round, most recently a $51.4M Series A round in Feb 2024. Investors include Pfizer Ventures, Columbus Venture Partners and Advent Life Sciences.